Parathyroid Hyperplasia Clinical Trial
Official title:
"Parathyroid Tissues Anatomic Localizations Are Displaced Downward in Parathyroid Hyperplasia Cases"
Verified date | December 2015 |
Source | SB Istanbul Education and Research Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | Turkey: Ethics Committee |
Study type | Observational |
This study investigates if Parathyroid Tissues Anatomic Localizations Are Displaced Downward in Parathyroid Hyperplasia Cases or not.
Status | Enrolling by invitation |
Enrollment | 125 |
Est. completion date | February 2016 |
Est. primary completion date | January 2016 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | N/A and older |
Eligibility |
Inclusion Criteria: - Patients who have undergone an operation due to parathyroid hyperplasia Exclusion Criteria: |
Observational Model: Cohort, Time Perspective: Prospective
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
SB Istanbul Education and Research Hospital |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Size of the thyroid tissue | Longitudinal size (in mm) of each parathyroid tissue according to its anatomical location (upper, middle or lower 1/3 of the thyroid gland or below the thyroid) | one year | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03469310 -
Minimizing Narcotic Analgesics After Endocrine Surgery
|
Phase 4 | |
Completed |
NCT04299425 -
Evaluating Impact of NIRAF Detection for Identifying Parathyroid Glands During Parathyroidectomy
|
N/A | |
Completed |
NCT03027557 -
Treatment of Primary Hyperparathyroidism With Denosumab and Cinacalcet.
|
Phase 3 | |
Withdrawn |
NCT01421407 -
Efficacy and Safety of High Intensity Focused Ultrasound (HIFU) Device to Treat Secondary Hyperparathyroidism
|
N/A |